Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron for Bipolar Disorder and Alcohol Use Disorders
NCT02082678Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Feb 2014
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ondansetron in bipolar disorder (BD), alcohol use disorder (AUD), cyclothymic disorder and 2 more, sponsored by UT Southwestern Medical Center. Started Feb 2014; status: completed.
02
Drugs
ondansetron
03
Conditions
bipolar disorder (BD)alcohol use disorder (AUD)cyclothymic disorderschizoaffective disordermajor depressive disorder (MDD)
Beyond the preview
Go deeper on NCT02082678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02082678.